Vastarel is an oral medication classified as a selective serotonin receptor antagonist used to treat certain gastrointestinal disorders. Its primary therapeutic purpose is to reduce symptoms such as nausea and delayed gastric emptying associated with functional dyspepsia. The drug acts by selectively blocking the 5-ht3 receptors in the central nervous system and gastrointestinal tract. This blockade prevents serotonin-mediated stimulation of vagal afferents that normally trigger nausea and emesis. Consequently, the propagation of nausea signals to the brainstem is attenuated, leading to improved patient comfort. In addition, Vastarel modulates intestinal motility by reducing serotonin-induced contractions of the stomach and small intestine. The combined effect of receptor antagonism and smooth muscle relaxation enhances gastric emptying and diminishes gastrointestinal discomfort. Overall, the pharmacological action of Vastarel relies on targeted serotonin receptor inhibition to achieve its therapeutic outcomes.

Vastarel is a medication whose active ingredient is trimetazidine and it is prescribed to reduce the frequency of angina attacks. Its main therapeutic role is to protect the heart muscle during episodes of reduced blood flow by improving its energy use. The drug does this by partially blocking the oxidation of fatty acids in the mitochondria, a process that normally consumes a lot of oxygen. When fatty-acid oxidation is reduced, the heart can switch to using glucose which yields more energy for each unit of oxygen consumed. This metabolic shift lowers the heart's oxygen demand and helps maintain stable function when blood supply is limited. Clinical trials have shown that Vastarel increases exercise capacity and decreases symptoms such as chest pain in patients with chronic stable angina.

Vastarel may cause mild gastrointestinal discomfort such as nausea or abdominal pain. Headache and dizziness are also reported among users of the medication. Some individuals experience insomnia or difficulty sleeping as a side effect. Skin reactions like rash or itching can occur in rare cases. Occasionally, changes in heart rhythm or palpitations have been noted. The medication may lead to increased uric acid levels in certain patients. These effects are generally mild and often resolve without intervention.

Headache may occur in some individuals taking Vastarel. Dizziness is another possible side effect. Nausea can be experienced by certain users. Fatigue might be reported during treatment. Visual disturbances such as blurred vision have been documented. Muscle cramps occasionally appear in patients. Insomnia may develop in some cases.